KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Edwards Lifesciences (EW) Income from Continuing Operations (2016 - 2026)

Edwards Lifesciences has reported Income from Continuing Operations over the past 17 years, most recently at 64200000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 81.39% year-over-year to 64200000.0; the TTM value through Dec 2025 reached 1056000000.0, down 24.36%, while the annual FY2025 figure was 1056000000.0, 24.36% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 64200000.0 at Edwards Lifesciences, down from 292300000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 489500000.0 in Q2 2021 and troughed at 64200000.0 in Q4 2025.
  • A 5-year average of 327090000.0 and a median of 339150000.0 in 2021 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 501.56% in 2021 and later tumbled 81.39% in 2025.
  • Year by year, Income from Continuing Operations stood at 335300000.0 in 2021, then crashed by 40.2% to 200500000.0 in 2022, then skyrocketed by 66.13% to 333100000.0 in 2023, then rose by 3.57% to 345000000.0 in 2024, then tumbled by 81.39% to 64200000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for EW at 64200000.0 in Q4 2025, 292300000.0 in Q3 2025, and 335900000.0 in Q2 2025.